KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Free Cash Flow: 2012-2024

Historic Free Cash Flow for Xenon Pharmaceuticals (XENE) over the last 13 years, with Dec 2024 value amounting to -$184.5 million.

  • Xenon Pharmaceuticals' Free Cash Flow fell 43.33% to -$72.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$253.3 million, marking a year-over-year decrease of 53.72%. This contributed to the annual value of -$184.5 million for FY2024, which is 17.70% down from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Free Cash Flow of -$184.5 million as of FY2024, which was down 17.70% from -$156.7 million recorded in FY2023.
  • Xenon Pharmaceuticals' 5-year Free Cash Flow high stood at -$50.8 million for FY2020, and its period low was -$184.5 million during FY2024.
  • For the 3-year period, Xenon Pharmaceuticals' Free Cash Flow averaged around -$148.4 million, with its median value being -$156.7 million (2023).
  • Data for Xenon Pharmaceuticals' Free Cash Flow shows a maximum YoY slumped of 752.55% (in 2020) over the last 5 years.
  • Xenon Pharmaceuticals' Free Cash Flow (Yearly) stood at -$50.8 million in 2020, then crashed by 40.96% to -$71.6 million in 2021, then tumbled by 45.24% to -$103.9 million in 2022, then tumbled by 50.81% to -$156.7 million in 2023, then declined by 17.70% to -$184.5 million in 2024.